Moreover, CDK2 was reported to promote cell viability and tumor progression in many other human cancers, including breast cancer 24, 25, colorectal cancer 26, squamous cell carcinoma of the head and neck 27, neuroblastoma 28 and nonsmall cell lung cancer 29. Here, CDK2 is linked to head and neck squamous cell carcinoma.